Page last updated: 2024-08-26

mafosfamide and Granulocytic Leukemia, Chronic, Stable Phase

mafosfamide has been researched along with Granulocytic Leukemia, Chronic, Stable Phase in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Calabretta, B; Malaguarnera, L; Nieborowska-Skórska, M; Ratajczak, MZ; Skórski, T; Szczylik, C1
Almici, C; Caramatti, C; Carlo-Stella, C; Garau, D; Mangoni, L; Piovani, G; Rizzoli, V1

Other Studies

2 other study(ies) available for mafosfamide and Granulocytic Leukemia, Chronic, Stable Phase

ArticleYear
Successful mafosfamide purging of bone marrow from chronic myelogenous leukemia (CML) cells.
    Folia histochemica et cytobiologica, 1993, Volume: 31, Issue:4

    Topics: Antineoplastic Agents; Blast Crisis; Bone Marrow; Bone Marrow Purging; Colony-Forming Units Assay; Cyclophosphamide; Drug Screening Assays, Antitumor; Humans; Leukemia, Myeloid, Chronic-Phase; Oligonucleotide Probes; Polymerase Chain Reaction; Tumor Cells, Cultured

1993
In vitro marrow purging in chronic myelogenous leukemia: effect of mafosfamide and recombinant granulocyte--macrophage colony-stimulating factor.
    Bone marrow transplantation, 1991, Volume: 8, Issue:4

    Topics: Adult; Aged; Antineoplastic Agents; Bone Marrow Purging; Bone Marrow Transplantation; Colony-Forming Units Assay; Cyclophosphamide; Evaluation Studies as Topic; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Chronic-Phase; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Male; Middle Aged

1991